480 related articles for article (PubMed ID: 26480326)
1. Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.
Cohen SA; Laurino M; Bowen DJ; Upton MP; Pritchard C; Hisama F; Jarvik G; Fichera A; Sjoding B; Bennett RL; Naylor L; Jacobson A; Burke W; Grady WM
Cancer; 2016 Feb; 122(3):393-401. PubMed ID: 26480326
[TBL] [Abstract][Full Text] [Related]
2. Comparative effectiveness of screening strategies for Lynch syndrome.
Barzi A; Sadeghi S; Kattan MW; Meropol NJ
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25794514
[TBL] [Abstract][Full Text] [Related]
3. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
[TBL] [Abstract][Full Text] [Related]
4. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.
Stoffel EM; Mangu PB; Gruber SB; Hamilton SR; Kalady MF; Lau MW; Lu KH; Roach N; Limburg PJ; ;
J Clin Oncol; 2015 Jan; 33(2):209-17. PubMed ID: 25452455
[TBL] [Abstract][Full Text] [Related]
5. Genetic counseling and cascade genetic testing in Lynch syndrome.
Hampel H
Fam Cancer; 2016 Jul; 15(3):423-7. PubMed ID: 26969309
[TBL] [Abstract][Full Text] [Related]
6. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
Schofield L; Goldblatt J; Iacopetta B
Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
[TBL] [Abstract][Full Text] [Related]
7. Association of patient navigation with care coordination in an Lynch syndrome screening program.
Miesfeldt S; Feero WG; Lucas FL; Rasmussen K
Transl Behav Med; 2018 May; 8(3):450-455. PubMed ID: 29800403
[TBL] [Abstract][Full Text] [Related]
8. Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing.
Frolova AI; Babb SA; Zantow E; Hagemann AR; Powell MA; Thaker PH; Gao F; Mutch DG
Gynecol Oncol; 2015 Apr; 137(1):7-13. PubMed ID: 25617771
[TBL] [Abstract][Full Text] [Related]
9. Selective Versus Universal Screening for Lynch Syndrome: A Six-Year Clinical Experience.
Kidambi TD; Blanco A; Myers M; Conrad P; Loranger K; Terdiman JP
Dig Dis Sci; 2015 Aug; 60(8):2463-9. PubMed ID: 24903654
[TBL] [Abstract][Full Text] [Related]
10. Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers.
Hunter JE; Zepp JM; Gilmore MJ; Davis JV; Esterberg EJ; Muessig KR; Peterson SK; Syngal S; Acheson LS; Wiesner GL; Reiss JA; Goddard KA
Cancer; 2015 Sep; 121(18):3281-9. PubMed ID: 26036338
[TBL] [Abstract][Full Text] [Related]
11. Adherence to guidelines for the referral of patients with colorectal cancer and abnormal tumour tissue testing for assessment of Lynch syndrome.
Han J; Spigelman AD
ANZ J Surg; 2019 Oct; 89(10):1281-1285. PubMed ID: 30856687
[TBL] [Abstract][Full Text] [Related]
12. Family matters in lynch syndrome.
Kastrinos F; Steyerberg EW
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25794515
[No Abstract] [Full Text] [Related]
13. Caring for patients at risk for hereditary colorectal cancer.
Greco K
Oncology (Williston Park); 2007 Feb; 21(2 Suppl Nurse Ed):29-38; discussion 39. PubMed ID: 17476735
[TBL] [Abstract][Full Text] [Related]
14. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.
Menko FH; Ter Stege JA; van der Kolk LE; Jeanson KN; Schats W; Moha DA; Bleiker EMA
Fam Cancer; 2019 Jan; 18(1):127-135. PubMed ID: 29846880
[TBL] [Abstract][Full Text] [Related]
15. Missed opportunities: Genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer.
Lee J; Gubernick LR; Brodsky AL; Fehniger JE; Levine DA; Gerber D; Asgari SA; Cantor A; Martineau JT; Ginsburg OM; Smith JA; Pothuri B
Gynecol Oncol; 2018 Oct; 151(1):153-158. PubMed ID: 30077346
[TBL] [Abstract][Full Text] [Related]
16. Using behaviour change and implementation science to address low referral rates in oncology.
Long JC; Debono D; Williams R; Salisbury E; O'Neill S; Eykman E; Butler J; Rawson R; Phan-Thien KC; Thompson SR; Braithwaite J; Chin M; Taylor N
BMC Health Serv Res; 2018 Nov; 18(1):904. PubMed ID: 30486812
[TBL] [Abstract][Full Text] [Related]
17. Comparing universal Lynch syndrome tumor-screening programs to evaluate associations between implementation strategies and patient follow-through.
Cragun D; DeBate RD; Vadaparampil ST; Baldwin J; Hampel H; Pal T
Genet Med; 2014 Oct; 16(10):773-82. PubMed ID: 24651603
[TBL] [Abstract][Full Text] [Related]
18. Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center.
Moline J; Mahdi H; Yang B; Biscotti C; Roma AA; Heald B; Rose PG; Michener C; Eng C
Gynecol Oncol; 2013 Jul; 130(1):121-6. PubMed ID: 23612316
[TBL] [Abstract][Full Text] [Related]
19. Increasing Lynch syndrome identification through establishment of a hereditary colorectal cancer registry.
Sturgeon D; McCutcheon T; Geiger TM; Muldoon RL; Herline AJ; Wise PE
Dis Colon Rectum; 2013 Mar; 56(3):308-14. PubMed ID: 23392144
[TBL] [Abstract][Full Text] [Related]
20. [Role of the PRED-IdF, a regional network dedicated to patients with hereditary predisposition to digestive cancers].
Perrod G; Samaha E; Bats AS; Cellier C
Ann Pathol; 2020 Apr; 40(2):114-119. PubMed ID: 32199653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
